Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hancock

Showing results (521-530 of 557) with videos related to

Pageof 56
Sort By:
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Scientific Reports|June 24, 2024
LLIN Evaluation in Uganda Project (LLINEUP)-effects of a vector control trial on Plasmodium infection prevalence and genotypic markers of insecticide resistance in Anopheles vectors from 48 districts of UgandaAmy Lynd, Samuel Gonahasa, Sarah G Staedke, et al.
Breast Cancer Research : BCR|August 7, 2019
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersBradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 21, 2006
Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H (3) receptor antagonistsA A Hancock, R S Bitner, K M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptorsJ A Gibbons, A A Hancock, C R Vitt, et al.
Journal of Medicinal Chemistry|June 1, 2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasiaM D Meyer, R J Altenbach, H Bai, et al.
Scientific Data|July 17, 2019
Analysis-ready datasets for insecticide resistance phenotype and genotype frequency in African malaria vectorsCatherine L Moyes, Antoinette Wiebe, Katherine Gleave, et al.
European Journal of Pharmacology|June 13, 2006
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxietyAna M Basso, Natalie A Bratcher, Kelly B Gallagher, et al.
Ergonomics|July 17, 2024
The Chartered Institute of Ergonomics and Human Factors at 75: perspectives on contemporary challenges and future directions for Ergonomics and Human FactorsPaul M Salmon, Catherine Burns, Suzy Broadbent, et al.
Pageof 56

Showing results (521-530 of 557) with videos related to

Sort By:
Pageof 56
Nature Communications|May 22, 2019
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progressionFilip Liebsch, Luka Kulic, Charlotte Teunissen, et al.
Scientific Reports|June 24, 2024
LLIN Evaluation in Uganda Project (LLINEUP)-effects of a vector control trial on Plasmodium infection prevalence and genotypic markers of insecticide resistance in Anopheles vectors from 48 districts of UgandaAmy Lynd, Samuel Gonahasa, Sarah G Staedke, et al.
Breast Cancer Research : BCR|August 7, 2019
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersBradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2004
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like propertiesTimothy A Esbenshade, Gerard B Fox, Kathleen M Krueger, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|March 21, 2006
Distinctions and contradistinctions between antiobesity histamine H(3) receptor (H (3)R) antagonists compared to cognition-enhancing H (3) receptor antagonistsA A Hancock, R S Bitner, K M Krueger, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptorsJ A Gibbons, A A Hancock, C R Vitt, et al.
Journal of Medicinal Chemistry|June 1, 2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasiaM D Meyer, R J Altenbach, H Bai, et al.
Scientific Data|July 17, 2019
Analysis-ready datasets for insecticide resistance phenotype and genotype frequency in African malaria vectorsCatherine L Moyes, Antoinette Wiebe, Katherine Gleave, et al.
European Journal of Pharmacology|June 13, 2006
Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxietyAna M Basso, Natalie A Bratcher, Kelly B Gallagher, et al.
Ergonomics|July 17, 2024
The Chartered Institute of Ergonomics and Human Factors at 75: perspectives on contemporary challenges and future directions for Ergonomics and Human FactorsPaul M Salmon, Catherine Burns, Suzy Broadbent, et al.
Pageof 56